Neoadjuvant Radiotherapy for High-risk UTUC
NCT06472752
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Urothelial Carcinoma of the Renal Pelvis and Ureter
Interventions
RADIATION:
Neoadjuvant radiotherapy
COMBINATION_PRODUCT:
Neoadjuvant drug therapy
Sponsor
Peking University First Hospital